Effect of pharmacist intervention on glycemic control in diabetes

Diabetes Research and Clinical Practice

Volumn 92, Issue 2, 2011, Pages 145-152

  Collins, Courtney ^a   Limone, Brendan L ^a   Scholle, Jennifer M ^a,b   Coleman, Craig I ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Medication therapy management; Meta analysis; Pharmacists

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

DIABETES EDUCATION; DIABETES MELLITUS; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; PATIENT COUNSELING; PHARMACIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF MONITORING; SYSTEMATIC REVIEW; TREATMENT PLANNING;

AGED; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955829254     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.09.023     Document Type: Review

References (20)

1. American Diabetes Association Standards of Medical Care in Diabetes-2010. Diabetes Care 2010, 33(1):S11-S48.
2. Shojania K.G., Ranji S.R., McDonal K.M., Grimshaw J.M., Rushakoff R.J., Owens D.K. Effects of quality improvement strategies for type 2 diabetes on glycemic control. Journal of the American Medical Association 2006, 296:427-440.
3. Follman D., Elliot P., Suh I., Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992, 45:769-773.
4. Al Mazroui N.R., Kamal M.M., Ghabash N.M., Yacout T.A., Kole P.L., McElnay J.C. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. British Journal of Clinical Pharmacology 2009, 67(5):547-557.
5. Choe H.M., Mitrovich S., Dubay D., Hayward R.A., Krein S.L., Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care 2005, 11(4):253-260.
6. Clifford R.M., Batty K.T., Davis T.M.E., Davis W., Stein G., Stewart G., et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. International Journal of Pharmacy Practice 2002, 10(2):85-89.
7. Clifford R.M., Batty K.T., Davis T.M.E., Davis W. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2005, 28(4):771-776.
8. Doucette W.R., Witry M.J., Farris K.B., McDonough R.P. Community pharmacist-provided extended diabetes care. Annals of Pharmacotherapy 2009, 43(5):882-889.
9. Fornos J.A., Andres N.F., Andres J.C., Guerra M.M., Egea B. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharmacy World & Science 2006, 28(2):65-72.
10. Jaber L.A., Halapy H., Fernet M., Tummalapalli S., Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy 1996, 30(3):238-243.
11. Jameson J., Baty P. Pharmacist collaboration management of poorly controlled diabetes mellitus: a randomized controlled trial. The American Journal of Managed Care 2010, 16(4):250-255.
12. Krass I., Armour C.L., Mitchell B., Brillant M., Dienaar R., Hughes J., et al. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine 2007, 24(6):677-683.
13. Odegard P.S., Goo A., Hummel J., Williams K.L., Gray S.L. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Annals of Pharmacotherapy 2005, 29(3). 433-430.
14. Phumipamorn S., Pongwecharak J., Soorapan S., Pattharachayakul S. Effects of the pharmacist's input on glycaemic control and cardiovascular risks in muslim diabetes. Primary Care Diabetes 2008, 2(1):31-37.
15. Rothman R.L., Malone R., Bryant B., Shintani A.K., Crigler B., Dewalt D.A., et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. American Journal of Medicine 2005, 118(3):276-284.
16. Sarkadi A., Rosenqvist U. Experience-based group education in type 2 diabetes: a randomised controlled trial. Patient Education and Counseling 2004, 53(3):291-298.
17. Suppapitiporn S., Chindavijak B., Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. Journal of the Medical Association of Thailand 2005, 88(4). S134-41.
18. Nathan D.M., Buse J.B., Davison M.B., Ferrannini E., Holman R.R., Sherwin R., et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009, 32(1):193-203.
19. Ellis S.E., Speroff T., Dittus R.S., Brown A., Pichert J.W., Elasy T.A. Diabetes patient education: a meta-analysis and meta-regression. Patient Education and Counseling 2004, 52(1):97-105.
20. Gary T.L., Genkinger J.M., Guallar E., Peyrot M., Brancati F.L. Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Education 2003, 29(3):488-501.